NCLEX-RN Pharmacology
Gastrointestinal System Exam Questions
& Answers
20 NGN-Style Practice MCQs with
Rationales
ATI Pharmacology Made Easy Review
|Nursing Study Guide 2026
Question 1
Clinical Scenario
A 58-year-old man is admitted with epigastric pain and
melena. He has a history of osteoarthritis and reports
taking ibuprofen 800 mg three times daily for several
months. The provider prescribes pantoprazole 40 mg IV
daily. Vital signs are BP 118/72 mm Hg, HR 92/min, RR
18/min, and temperature 37.1°C (98.8°F). Laboratory
results show hemoglobin 10.4 g/dL and hematocrit 31%.
,Question Stem
Which therapeutic response indicates that pantoprazole
is achieving its intended effect?
A. Increased gastric emptying
B. Decreased gastric acid secretion promoting ulcer
healing
C. Increased intestinal motility
D. Neutralization of existing stomach acid
Correct Answer
B. Decreased gastric acid secretion promoting ulcer
healing
Detailed Rationale
Pantoprazole is a proton pump inhibitor (PPI) that
irreversibly inhibits the hydrogen-potassium ATPase
pump located in gastric parietal cells. This action
suppresses the final step of gastric acid production,
making PPIs the most effective medications for reducing
gastric acidity and promoting healing of peptic ulcers,
erosive esophagitis, and upper gastrointestinal bleeding
associated with NSAID use. In this patient, decreased acid
,production allows damaged gastric mucosa to heal while
reducing the risk of recurrent bleeding.
Option A is incorrect because increasing gastric emptying
is the action of prokinetic medications such as
metoclopramide, not PPIs.
Option C is incorrect because pantoprazole has minimal
effect on intestinal motility.
Option D is incorrect because antacids neutralize acid
already present in the stomach, whereas pantoprazole
prevents new acid production. Understanding this
distinction helps nurses explain why symptom relief from
PPIs may take longer than from antacids.
Nursing considerations include administering IV
pantoprazole as prescribed, monitoring hemoglobin,
hematocrit, stool color, and signs of continued bleeding.
Long-term therapy may increase the risk for fractures,
hypomagnesemia, vitamin B12 deficiency, and
Clostridioides difficile infection. Patients should also be
counseled to avoid unnecessary NSAID use.
Learning Objective
, After completing this question, the learner should be
able to:
• Explain the mechanism of action of proton pump
inhibitors.
• Evaluate therapeutic responses to pantoprazole
therapy.
• Differentiate PPIs from antacids.
• Monitor patients receiving acid-suppressive therapy.
Medication Safety Focus: Monitoring
Question 2
Clinical Scenario
A 27-year-old woman is prescribed sucralfate for a newly
diagnosed duodenal ulcer. During discharge teaching, the
nurse reviews medication administration. The patient
also takes levothyroxine every morning and a daily
multivitamin.
Question Stem
Gastrointestinal System Exam Questions
& Answers
20 NGN-Style Practice MCQs with
Rationales
ATI Pharmacology Made Easy Review
|Nursing Study Guide 2026
Question 1
Clinical Scenario
A 58-year-old man is admitted with epigastric pain and
melena. He has a history of osteoarthritis and reports
taking ibuprofen 800 mg three times daily for several
months. The provider prescribes pantoprazole 40 mg IV
daily. Vital signs are BP 118/72 mm Hg, HR 92/min, RR
18/min, and temperature 37.1°C (98.8°F). Laboratory
results show hemoglobin 10.4 g/dL and hematocrit 31%.
,Question Stem
Which therapeutic response indicates that pantoprazole
is achieving its intended effect?
A. Increased gastric emptying
B. Decreased gastric acid secretion promoting ulcer
healing
C. Increased intestinal motility
D. Neutralization of existing stomach acid
Correct Answer
B. Decreased gastric acid secretion promoting ulcer
healing
Detailed Rationale
Pantoprazole is a proton pump inhibitor (PPI) that
irreversibly inhibits the hydrogen-potassium ATPase
pump located in gastric parietal cells. This action
suppresses the final step of gastric acid production,
making PPIs the most effective medications for reducing
gastric acidity and promoting healing of peptic ulcers,
erosive esophagitis, and upper gastrointestinal bleeding
associated with NSAID use. In this patient, decreased acid
,production allows damaged gastric mucosa to heal while
reducing the risk of recurrent bleeding.
Option A is incorrect because increasing gastric emptying
is the action of prokinetic medications such as
metoclopramide, not PPIs.
Option C is incorrect because pantoprazole has minimal
effect on intestinal motility.
Option D is incorrect because antacids neutralize acid
already present in the stomach, whereas pantoprazole
prevents new acid production. Understanding this
distinction helps nurses explain why symptom relief from
PPIs may take longer than from antacids.
Nursing considerations include administering IV
pantoprazole as prescribed, monitoring hemoglobin,
hematocrit, stool color, and signs of continued bleeding.
Long-term therapy may increase the risk for fractures,
hypomagnesemia, vitamin B12 deficiency, and
Clostridioides difficile infection. Patients should also be
counseled to avoid unnecessary NSAID use.
Learning Objective
, After completing this question, the learner should be
able to:
• Explain the mechanism of action of proton pump
inhibitors.
• Evaluate therapeutic responses to pantoprazole
therapy.
• Differentiate PPIs from antacids.
• Monitor patients receiving acid-suppressive therapy.
Medication Safety Focus: Monitoring
Question 2
Clinical Scenario
A 27-year-old woman is prescribed sucralfate for a newly
diagnosed duodenal ulcer. During discharge teaching, the
nurse reviews medication administration. The patient
also takes levothyroxine every morning and a daily
multivitamin.
Question Stem
